Clermont-Ferrand, 18 June 2018 – (FR0004177046 METEX), METabolic EXplorer (METEX), an industrial biochemistry company specializing in the development and marketing of industrial fermentation processes for a sustainable chemical production, announced today that it has received the results of the detailed engineering study on the first phase of construction of a plant for the production of 1.3-propanediol (PDO) and butyric acid (BA) on the Carling site in Moselle.
This detailed study, conducted by a leading engineering firm, confirms the required investment capital of €29 million to be paid by the joint venture. This investment will cover the first 6 kt stage of the production plant’s construction (5 kt of PDO and 1 kt of BA) on the Carling petrochemical redevelopment site in Moselle.
This study also confirms that an investment capital of €15 million is needed to adapt the site to house its first industrial biochemical facility (buildings, utilities, roads, etc.). METabolic EXplorer reminds that the investment is now mainly subject to obtaining, at the end of June, financing in this €15 million amount from the public and private stakeholders committed to economic and social development of the platform.
Antoine Darbois, Secretary General of METabolic Explorer, said: “The results of this new study, conducted by one of the leaders in the sector, are in line with our expectations. This demonstrates the level of our control of the industrial process and is an additional token of METEX’s confidence for its public and private financial partners.”
– END –
About METabolic EXplorer – www.metabolic-explorer.com
A pioneer in industrial biochemistry with some 20 years of experience, METabolic Explorer (METEX) develops alternative solutions to the petrochemical processes used in manufacturing.
Using renewable raw materials, it develops innovative industrial fermentation processes to produce competitive chemical compounds used in basic products of everyday life such as animal nutrition and health additives, plastics, textiles, cosmetics, and resins, among many others.
The company’s ambition with its biotechnological innovations is to produce consumer goods in a different way, without oil, in order to meet consumers’ new societal expectations and the objectives of the energy transition and sustainable development.
To create these innovative processes, METabolic EXplorer relies on a 70-person staff possessing the complementary competencies essential at every step of their development, from the optimization of biochemical catalysts in the laboratory to the industrial validation and production of samples in an industrial demonstration unit in continuous operation.
Based at the Clermont Limagne technology park, near Clermont-Ferrand, METabolic Explorer is listed on Euronext in Paris (Compartment C, METEX) and is included in the CAC Small Index.
Get free financial information on METabolic EXplorer by registering with:
Investor relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : email@example.com
Media relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : firstname.lastname@example.org